Short-chain fatty acid production via colonic fermentation

Colonic fermentation-mediated short-chain fatty acid production refers to the metabolic conversion of indigestible carbohydrates and some amino acids into volatile fatty acids—primarily acetate, propionate, and butyrate—by the gut microbiota under anaerobic conditions. These products are critical for colon health, serve as energy sources for host cells, regulate local and systemic metabolism, modulate immune responses, and influence the gut-brain axis. The magnitude and profile of SCFA production depend on dietary intake, physical characteristics of fiber, and the composition/function of gut microbiota. Research connects SCFA production to protection against inflammation, several metabolic diseases, and colorectal cancer, while experimental increases (via diet or supplementation) are being assessed for therapeutic potential.

Other names

Short-chain fatty acid synthesisColonic fermentation SCFA outputGut microbial SCFA production

This is a metabolic process, not a receptor or enzyme, and as such, there are no direct drug mechanisms of action for targeting the process itself. Indirect mechanisms involve dietary fiber, prebiotics, and probiotics that increase SCFA production. There are no known drugs directly targeting this process. Experimental interventions include direct supplementation with acetate, propionate, or butyrate.